Showing results (141-150 of 192) with videos related to

Sort By:
Pageof 20
Oncoimmunology|November 20, 2012
Tumor cells, rather than dendritic cells, deliver antigen to the lymph node for cross-presentationAlison M McDonnell, Andrew J Currie, Matthew Brown, et al.
Clinical Proteomics|February 24, 2016
Erratum to: ENOX2-based early detection (ONCOblot) of asbestos-induced malignant mesothelioma 4-10 years in advance of clinical symptomsD James Morré, Brandon Hostetler, David J Taggart, et al.
Cancer Research|November 17, 2006
A novel SV40 TAg transgenic model of asbestos-induced mesothelioma: malignant transformation is dose dependentCleo Robinson, Ivonne van Bruggen, Amanda Segal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 24, 2010
Serum soluble mesothelin concentrations in malignant pleural mesothelioma: relationship to tumor volume, clinical stage and changes in tumor burdenJenette Creaney, Roslyn J Francis, Ian M Dick, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 23, 2008
Targeting the effector site with IFN-alphabeta-inducing TLR ligands reactivates tumor-resident CD8 T cell responses to eradicate established solid tumorsAndrew J Currie, Robbert G van der Most, Steve A Broomfield, et al.
BMC Cancer|December 19, 2015
Consistent gene expression profiles in MexTAg transgenic mouse and wild type mouse asbestos-induced mesotheliomaCleo Robinson, Ian M Dick, Michael J Wise, et al.
Pageof 20